- Dendreon (DNDN) Q2 misses on all counts
- The company notes that the competitive environment remains largely unchanged from the first quarter.
- Based upon current enrollment trends in July and August, it doesn't expect to see enough of a sales increase in H2 to meet its goal of growing Provenge Y/Y.
- The company currently has $280.6M in cash, cash equivalents, and short-term and long-term investments, compared to $429.8M as of December 31, 2012.
- Shares -12% AH.
More on Dendreon earnings
Aug 8 2013, 16:48 ET